Andrew Kavasilas Interview Regarding Medical Cannabis Limited and Vitahemp
Sydney, May 24, 2017 AEST (ABN Newswire) - Queensland Bauxite Ltd (
ASX:QBL) are pleased to provide an announcement regarding Andrew Kavasilas, Technical Director of Medical Cannabis Limited (MCL), who has been interviewed by 2Ser 107.3 in relation to the work that he has been doing with Medical Cannabis Limited and Vitahemp, and in preparation for the upcoming Hemp Health and Innovation Expo, Australia's largest Cannabis Expo. Andrew also discussed general information on the industry and Cannabis.
Shareholders are welcome to see some of the work of MCL being displayed at the Expo this coming Sunday at Rosehill Racecourse. Shareholders will have the opportunity to meet Mr Kavasilas and other MCL personnel at the expo.
The interview can be accessed at the following web page: http://www.abnnewswire.net/lnk/952J441L
Pnina Feldman, Executive Chairperson of Queensland Bauxite says "The team at Queensland Bauxite are delighted with its association with the fascinating work being undertaken by MCL, and are hopeful that QBL's investment in MCL will continue exponentially to be of benefit to QBL shareholders.
"We believe in the vast amazing opportunities currently being offered worldwide by developments in the Cannabis and hemp industries and feel privileged through our investment to be a part of this opportunity benefitting so many people throughout the world, with so much more potential to come as new avenues are being explored worldwide and new horizons open up here in Australia.
"It is interesting to note that a recent trial conducted by the Hebrew University of Jerusalem Israel, has successfully reversed memory loss and other cognitive ageing symptoms in mice treated with low doses of THC. Clinical trials will now begin in humans."
For further information please see the article released by the Hebrew University:
http://www.abnnewswire.net/lnk/L72IRR14
New and exciting research into the benefits of medicinal Cannabis is continually emerging and as MCL progresses in its own research in partnership with experts in the field, announcements will be made as they become material. MCL through its experience, contacts, unique seed bank and licenses is in an excellent first mover position to take commercial advantage of these advancements as they develop.
Fore more information about Hemp Health an Innovation Expo, please visit:
http://www.hhiexpo.com.au
About Queensland Bauxite Ltd
Queensland Bauxite Limited (ASX:QBL) is an Australian listed company focused on the exploration and development of its bauxite tenements in Queensland and New South Wales. The Company's lead project is the South Johnstone Bauxite Deposit in northern Queensland which has rail running through the project area and is approximately 15-24 kilometres from the nearest deep water port. The Company intends to become a bauxite producer with a focus on commencing production at South Johnstone as early as possible. The Company also pursues additional investment opportunities, and has agreed to acquire a 100% shareholding in Medical Cannabis Limited, an Australian leader in the hemp and Cannabis industries, and a 100% shareholding in Medcan Australia Pty Ltd, a company with an ODC cultivation and production License and a DA approved Cannabis production and manufacturing facility.
| ||
|
